Aurobindo forays into Indonesia with acquisition of 15 brands for $48 million

Aurobindo Pharma announced on Tuesday that it is entering the Indonesian market by acquiring 15 formulations brands from Viatris Inc and Pfizer Inc for a cash consideration of US$48 million (approximately Rs 398 crore).